Literature DB >> 17560982

Surgical therapy of bone metastases.

Albert J Aboulafia1, Alan M Levine, Daniel Schmidt, David Aboulafia.   

Abstract

The treatment of patients with cancer epitomizes the importance of using a collaborative team approach to optimize patient care. Physician team members most commonly are radiation oncologists, general surgeons, surgical oncologists, thoracic surgeons, neurosurgeons, and orthopedic surgeons. When patients are receiving chemotherapy, their medical oncologist frequently takes responsibility for coordinating care among the various team members and initiating consultations with necessary providers. When patients develop bone metastases or chemotherapy-induced bone loss (CTIBL), the orthopedic surgeon may be able to improve the patient's quality of life greatly. Procedures orthopedists perform most commonly include open reduction and internal fixations and arthroplasties (joint replacement surgery). Less invasive procedures currently being tested include stereotactic radiosurgery, radiofrequency ablation (RFA), and percutaneous cementoplasty. By understanding the options available to patients with skeletal complications of malignancy, the medical oncologist can discuss issues with patients and make appropriate referrals for diagnosis and treatment. Additionally, with a greater understanding of the surgical procedures available, the medical oncologist will be better able to assist in preparing the patient for surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560982     DOI: 10.1053/j.seminoncol.2007.03.002

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  12 in total

Review 1.  Biomaterial scaffolds for treating osteoporotic bone.

Authors:  Julie A Sterling; Scott A Guelcher
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

2.  Image-guided minimally invasive percutaneous treatment of spinal metastasis.

Authors:  Ping-Lin Yang; Xi-Jing He; Hao-Peng Li; Quan-Jin Zang; Guo-Yu Wang
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

Review 3.  Engineering 3D Models of Tumors and Bone to Understand Tumor-Induced Bone Disease and Improve Treatments.

Authors:  Kristin A Kwakwa; Joseph P Vanderburgh; Scott A Guelcher; Julie A Sterling
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

Review 4.  Computer-Assisted Surgical Navigation for Primary and Metastatic Bone Malignancy of the Pelvis: Current Evidence and Future Directions.

Authors:  Alexander B Christ; Derek G Hansen; John H Healey; Nicola Fabbri
Journal:  HSS J       Date:  2021-07-07

5.  Preliminary results: use of multi-hole injection nails for intramedullary nailing with simultaneous bone cement injection in long-bone metastasis.

Authors:  Jong Woong Park; Yong-Il Kim; Hyun Guy Kang; June Hyuk Kim; Han Soo Kim
Journal:  Skeletal Radiol       Date:  2018-06-21       Impact factor: 2.199

Review 6.  The surgical treatment of pelvic bone metastases.

Authors:  Daniel A Müller; Rodolfo Capanna
Journal:  Adv Orthop       Date:  2015-02-24

7.  Dual-functional porous and cisplatin-loaded polymethylmethacrylate cement for reconstruction of load-bearing bone defect kills bone tumor cells.

Authors:  Zhule Wang; Liebert Parreiras Nogueira; Håvard Jostein Haugen; Ingrid Cm Van Der Geest; Patricia Caetano de Almeida Rodrigues; Dennis Janssen; Thom Bitter; Jeroen J J P van den Beucken; Sander Cg Leeuwenburgh
Journal:  Bioact Mater       Date:  2021-12-29

8.  Clinical features and outcomes of metastatic bone tumors of the pelvis.

Authors:  Qing Yang; Nong Chen; Wenqin Fu
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

Review 9.  Skeletal metastasis: treatments, mouse models, and the Wnt signaling.

Authors:  Kenneth C Valkenburg; Matthew R Steensma; Bart O Williams; Zhendong Zhong
Journal:  Chin J Cancer       Date:  2013-01-18

Review 10.  Multimodal Treatment of Bone Metastasis-A Surgical Perspective.

Authors:  Henry Soeharno; Lorenzo Povegliano; Peter F Choong
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.